LIGAND PHARMACEUTICALS INC

Company

LIGAND PHARMACEUTICALS INC

Filed

February 14, 2014

Accession Number

0001193125-14-051937

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →